Monday, April 29, 2019
MZ Digital Marketing Agency
from Reuters: Health News https://reut.rs/2PCnbA5
Monday, April 29, 2019
Monday, April 29, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Gilead Sciences Inc's experimental drug aimed at treating a type of fatty liver disease known as NASH failed to meet the main goal of a late-stage study on Thursday, two months after it failed another trial.
from Reuters: Health News https://reut.rs/2PCnbA5
from Reuters: Health News https://reut.rs/2PCnbA5
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment